Fast-growing Higi names executive chairman

Press enter to search
Close search
Open Menu

Fast-growing Higi names executive chairman

By Gina Acosta - 07/31/2018
Higi has partnered with many food retailers, including Wegmans and Publix, and now operates a nationwide network of over 11,000 FDA-cleared self-screening stations found at pharmacy retailers and other community locations and over 80 different third-party

A few weeks after raising $21.3 million in its latest funding round, health services firm Higi has named a new executive chairman.

Incoming Higi Executive Chairman Dr. Chris Kryder, a veteran of the healthcare information technology arena, has decades of experience leading and growing healthcare IT companies. He joins a board of directors that includes Dr. Robert Wah, former president of the American Medical Association, and Peter Neupert, former General Manager of Microsoft Health and CEO of Drugstore.com.  

Dr. Kryder takes on the role as executive chairman following the company’s latest fundraising round of $21.3 million from existing and new investors including Boston-based Flare Capital Partners, where Dr. Kryder is an executive partner, and Chicago-based 7wireVentures.  With this latest investment, Dr. Kryder and the board will focus on accelerating the development of higi’s applications that connect consumers and their data directly into the workflow of at-risk healthcare organizations. 

Higi has partnered with many food retailers, including Wegmans and Publix, and now operates a nationwide network of over 11,000 FDA-cleared self-screening stations found at pharmacy retailers and other community locations and over 80 different third-party integrations.

“It’s a terrific time to be in healthcare services, as technology - particularly remote diagnostics and monitoring - is improving the delivery of patient care, and as retail organizations are opening a new front door. higi’s machines meet consumers where they shop, and transmit data securely into the workflow of their doctors. This is likely to be a significant part of the future of healthcare, and I’m proud, as higi moves into high growth phase, to be part of it,” said Dr. Kryder. 

Most recently, Dr. Kryder served as Chairman of Valence Health from 2012-2016, which merged with EvolentHealth (NASDAQ: EVH) in 2016. He was the Founder and CEO of the analytics vendor D2Hawkeye, and then CEO of Verisk Health after Verisk’s IPO (NASDAQ: VRSK) in 2009. Dr. Kryder also co-founded Generation Health, the first genetic testing benefits manager, which sold to CVS Caremark in 2010.    

In addition to his business accomplishments, Dr. Kryder maintains his medical license in Massachusetts. He was formerly a primary care internist at the Medical Department at the Massachusetts Institute of Technology, where he also managed clinical operations. He was also active on the faculty of Harvard Medical School, Division of Health, Science, and Technology for more than 25 years. Massachusetts Governor Baker recently named Dr. Kryder as the physician representative on the Massachusetts Health Policy Commission. 

 

 

RELATED TOPICS